StockData
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30

Rezolute, Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 24, 2026
$3.70+0.12 (+3.35%)

Close on Oct 19, 2026

Market cap
$386.60M
P/E (TTM)
–
Dividend yield
–

Rezolute, Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-59.0%

Financial strength

Current ratio
9.68
Debt to equity
–
Debt to assets
–
Cash to current liabilities
93.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
3.84
Dividend yield
–